| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.177 | 2.227 | 10.878 | 74.166 | 65.211 | 37.240 | 70.118 | 80.510 | 59.274 | 72.511 |
| Total Income - EUR | 2.177 | 2.227 | 10.878 | 74.166 | 65.211 | 41.132 | 70.118 | 81.544 | 59.274 | 72.511 |
| Total Expenses - EUR | 22.854 | 11.155 | 15.613 | 36.003 | 40.600 | 33.805 | 31.628 | 37.481 | 49.027 | 47.699 |
| Gross Profit/Loss - EUR | -20.676 | -8.928 | -4.735 | 38.162 | 24.612 | 7.327 | 38.490 | 44.063 | 10.247 | 24.812 |
| Net Profit/Loss - EUR | -20.742 | -8.996 | -4.878 | 37.421 | 23.960 | 6.955 | 37.789 | 43.247 | 9.654 | 23.069 |
| Employees | 1 | 1 | 1 | 4 | 3 | 2 | 2 | 3 | 2 | 2 |
Check the financial reports for the company - Psihomedica Catharsis Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 115.556 | 107.146 | 95.402 | 86.432 | 77.289 | 69.384 | 66.821 | 94.165 | 89.016 | 83.709 |
| Current Assets | 940 | 707 | 2.724 | 8.976 | 41.869 | 27.465 | 34.566 | 12.191 | 27.127 | 55.122 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.517 |
| Receivables | 322 | 449 | 609 | 1.802 | 907 | 2.726 | 14.471 | 71 | 131 | 630 |
| Cash | 618 | 258 | 2.114 | 7.174 | 40.962 | 24.738 | 20.095 | 12.120 | 26.996 | 52.975 |
| Shareholders Funds | -64.163 | -72.508 | -76.158 | -37.339 | -12.657 | -5.462 | 32.448 | 58.560 | 68.037 | 90.726 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 181.013 | 180.660 | 174.284 | 132.747 | 131.814 | 102.310 | 68.939 | 47.796 | 48.107 | 48.106 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Psihomedica Catharsis Srl